StockWatch
·
Pharmaceuticals
Management Change25 Aug 2026, 05:00 pm

Bacil Pharma Appoints Two New Directors to Board

AI Summary

Bacil Pharma Limited announced the appointment of two new directors to its Board of Directors during a meeting held on August 25, 2026. Mr. Mahesh Singh has been appointed as a Non-Executive Independent Director, bringing over seven years of experience in trading, product sales, brand establishment, and business development, with expertise in online sales strategies and marketplace expansion. Mr. Anil Shiv Charan Singh has been appointed as a Non-Executive Director, contributing his experience in business management and commercial activities. Both appointments are subject to shareholder approval and the directors have provided necessary declarations and confirmations, confirming they are not debarred from holding office. These appointments aim to strengthen the company's board with diverse expertise.

Key Highlights

  • Bacil Pharma appointed Mr. Mahesh Singh as Non-Executive Independent Director.
  • Mr. Anil Shiv Charan Singh appointed as Non-Executive Director.
  • Both appointments are subject to shareholder approval.
  • New directors bring expertise in trading and business management.
  • Directors confirmed no debarment from regulatory authorities.